Newsletter | May 13, 2025

05.13.25 -- Challenges In Manufacturing TIL For Clinical Trials

SPONSOR

Webinar: Mastering the Complexities of Gene Therapy Document Writing

Gene therapy is complex—and so is writing about it. From viral vectors to cell types, every element demands deep understanding. Safety reporting adds further complexity: is an adverse event from chemotherapy, a procedure, or the gene therapy itself? These challenges require a thoughtful, flexible approach to document strategy and execution. Explore common hurdles and practical solutions for gene therapy document writing and submissions.

FEATURED EDITORIAL

Challenges In Manufacturing TIL For Clinical Trials

Tumor-infiltrating lymphocyte cell therapy shows promise for treating solid tumors, but its complex manufacturing profile brings a unique set of issues. Here are some things to watch out for.

INDUSTRY INSIGHTS

Strategies For Efficient Clinical Supply Management And Forecasting

Drive excellence in clinical trials by utilizing forecasting to better plan clinical supply budgets and project timelines, and identify potential supply-related issues before they negatively impact a study.

Proactive Strategies To Evaluate And Mitigate Clinical Supply Risk

Learn about strategies that can help build an understanding of risk assessment, in addition to how a study’s protocol requirements, packaging specifications, and more must be identified and addressed.

The Difference Between A Traditional IRT And Rave RTSM

Examine the differences between Traditional IRT and Rave RTSM, highlighting key attributes like workflow integration, user management, and overall impact on clinical trial operations.

SOLUTIONS

Navigating The Use Of Controlled Substances In Clinical Trials Using IRT